AbbVie
ABBV
#30
Rank
NZ$496.96 B
Marketcap
$281.23
Share price
-2.74%
Change (1 day)
21.32%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.15 B-33.3%
2023NZ$0.22 B-63.52%
2022NZ$0.62 B629.28%
2021NZ$86.13 M-77.97%
2020NZ$0.39 B85.64%
2019NZ$0.21 B-52.97%
2018NZ$0.44 B269.88%
2017NZ$0.12 B-48.45%
2016NZ$0.23 B-37.53%
2015NZ$0.37 B-44.13%
2014NZ$0.67 B2387.79%
2013NZ$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$50.21 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.95 MNZ$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.73 MNZ$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.74 MNZ$0.23 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.33 MNZ$0.23 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.66 MNZ$69.08 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.89 MNZ$55.2 M๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$31.61 MNZ$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$6.22 MNZ$28.49 M๐Ÿ‡บ๐Ÿ‡ธ USA